V W Henderson
Overview
Explore the profile of V W Henderson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sundboll J, Darvalics B, Horvath-Puho E, Adelborg K, Laugesen K, Schmidt M, et al.
J Thromb Haemost
. 2018 Sep;
16(11):2175-2183.
PMID: 30179297
Essentials The risk of thrombosis among ischemic stroke patients using glucocorticoids is unknown. We examined the risk of thrombosis in 98 487 ischemic stroke patients, by glucocorticoid use. Myocardial infarction...
2.
Henderson V
Climacteric
. 2018 Jun;
21(4):333-340.
PMID: 29852783
Progesterone is a neurosteroid and a neuroactive steroid, produced primarily by the corpus luteum and the placenta. In some animal models, progesterone affects cognitive performance, and its potential role in...
3.
Corraini P, Szepligeti S, Henderson V, Ording A, Horvath-Puho E, Sorensen H
J Thromb Haemost
. 2017 Nov;
16(2):242-252.
PMID: 29171148
Summary: Background Comorbidity is prevalent among stroke patients, affecting post-stroke survival. It remains unknown whether comorbidity impacts post-stroke mortality beyond the combined individual effects of stroke and comorbidity. Methods Using...
4.
Corraini P, Ording A, Henderson V, Szepligeti S, Hovath-Puho E, Sorensen H
Thromb Res
. 2016 May;
140 Suppl 1:S178.
PMID: 27161694
Introduction: The impact of comorbidity and in particular cancer on the risk of venous thromboembolism (VTE) after stroke is poorly understood. Aim: We aimed to determine the impact of comorbidity,...
5.
Lehert P, Villaseca P, Hogervorst E, Maki P, Henderson V
Climacteric
. 2015 Sep;
18(5):678-89.
PMID: 26361790
A number of health and lifestyle factors are thought to contribute to cognitive decline associated with age but cannot be easily modified by the individual patient. We identified 12 individually...
6.
Lobo R, Davis S, de Villiers T, Gompel A, Henderson V, Hodis H, et al.
Climacteric
. 2014 Jun;
17(5):540-56.
PMID: 24969415
Women may expect to spend more than a third of their lives after menopause. Beginning in the sixth decade, many chronic diseases will begin to emerge, which will affect both...
7.
Henderson V
Climacteric
. 2014 Jun;
17 Suppl 2:38-46.
PMID: 24893836
The slow, progressive accumulation of pathology characteristic of Alzheimer's disease is the principal determinant of cognitive decline leading to dementia. Risk-reduction strategies during midlife focus on raising the clinical threshold...
8.
Paganini-Hill A, Henderson V
Int J Pharm Compd
. 2013 Aug;
2(1):24-9.
PMID: 23989480
No abstract available.
9.
de Villiers T, Pines A, Panay N, Gambacciani M, Archer D, Baber R, et al.
Climacteric
. 2013 May;
16(3):316-37.
PMID: 23672656
No abstract available.
10.
Henderson V, St John J, Hodis H, Kono N, McCleary C, Franke A, et al.
Neurology
. 2012 Jun;
78(23):1841-8.
PMID: 22665144
Objective: To determine the cognitive effects of long-term dietary soy isoflavones in a daily dose comparable to that of traditional Asian diets. Methods: In the double-blind Women's Isoflavone Soy Health...